SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-22-001162
Filing Date
2022-08-12
Accepted
2022-08-12 07:00:26
Documents
13
Period of Report
2022-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e621868_8k-plx.htm   iXBRL 8-K 26530
2 e621868_ex99-1.htm EX-99.1 110976
  Complete submission text file 0001193805-22-001162.txt   324615

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA plxp-20220812.xsd EX-101.SCH 2962
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE plxp-20220812_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION plxp-20220812_pre.xml EX-101.PRE 22361
7 EXTRACTED XBRL INSTANCE DOCUMENT e621868_8k-plx_htm.xml XML 3577
Mailing Address 9 FISHERS LANE SUITE E SPARTA NJ 07871
Business Address 9 FISHERS LANE SUITE E SPARTA NJ 07871 (713) 842-1249
PLx Pharma Inc. (Filer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36351 | Film No.: 221157778
SIC: 2834 Pharmaceutical Preparations